A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)

This study has been completed.

Study NCT00044057 Information provided by Astellas Pharma Inc

First Received: August 16, 2002 Last Updated: March 31, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	January 2003
Estimated Primary Completion Date:	No date given